The global hip replacement implants market is expected to grow at a compound annual growth rate of 3.9 percent to reach more than $9.1 billion by 2024, according to a Market Research Engine report.
Spinal Tech
Stryker laid out plans to expand its industrial development district to cover an entire 79-acre site in Portage, Mich., according to mlive.com.
Stryker is making a takeover bid to acquire Boston Scientific, according to those "familiar with the matter," The Wall Street Journal reports.
After recently receiving FDA approval, Medacta announced its Unconstrained Screw Technology Sacro-Iliac Joint Screw System was used in its first sacroiliac joint fusion surgery.
OrthoSensor received FDA 510(k) clearance for its Verasense Sensor-Assisted Technology to be used with Zimmer Biomet's Persona Knee System for total knee replacement.
NuVasive appointed Lisa Pecora, Tristan Ribar and Marc Rosenbaum to finance roles.
North America will continue to drive the global neurostimulation devices market through 2024, according to a Brand Essence Market Research report.
K2M earned FDA clearance of its OZARK Cervical Plate Systems. The company surpassed its 100th product milestone since this clearance.
A judge ruled a former Medtronic's whistleblower lawsuit will go to trial, despite the company's efforts to have the case dismissed, according to Reuters.
Here are 11 key notes for orthopedic and spine device companies in the past week.
